To determine the efficacy of Lenstatin™, an over-the-counter nutritional supplement, in inhibiting the progression of nuclear cataract in eyes after pars plana vitrectomy.


  • Physician Assistant: Clinical Pharmacology, Ophthalmology, Ophthalmology: Clinical Pharmacology, Refractive/Eye
  • Surgery; Pharmacy: Other Drugs
  • Sponsor: Lenstatin LLC
  • Study Start Date: May 2014

Estimated Completion Date: December 2014


  • Dietary Supplement: Lenstatin
  • Drug: Placebo

Inclusion Criteria

  • Adults over the age of 18
  • Post pars plana vitrectomy surgery

Exclusion Criteria

  • Pediatric patients under the age of 18
  • Pregnant women
  • Hypersensitivity to any of the ingredients in Lenstatin

Study Locations And Contact Information

  • Scott W Tunis MD FACS, Wilmington North Carolina

Learn more: